Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $4.88 in the prior trading day, Aurora Cannabis Inc (NASDAQ: ACB) closed at $4.54, down -6.97%. In other words, the price has decreased by -$6.97 from its previous closing price. On the day, 1.8 million shares were traded. ACB stock price reached its highest trading level at $4.76 during the session, while it also had its lowest trading level at $4.25.
Ratios:
Our goal is to gain a better understanding of ACB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.51 and its Current Ratio is at 2.97. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.07.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACB now has a Market Capitalization of 257483424 and an Enterprise Value of 254533920. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.00 while its Price-to-Book (P/B) ratio in mrq is 0.63. Its current Enterprise Value per Revenue stands at 0.711 whereas that against EBITDA is 21.462.
Stock Price History:
The Beta on a monthly basis for ACB is 0.25, which has changed by -0.046875 over the last 52 weeks, in comparison to a change of 0.15566266 over the same period for the S&P500. Over the past 52 weeks, ACB has reached a high of $6.91, while it has fallen to a 52-week low of $3.42. The 50-Day Moving Average of the stock is -13.48%, while the 200-Day Moving Average is calculated to be -7.66%.
Shares Statistics:
The stock has traded on average 1.76M shares per day over the past 3-months and 1042920 shares per day over the last 10 days, according to various share statistics. A total of 56.25M shares are outstanding, with a floating share count of 56.13M. Insiders hold about 0.57% of the company’s shares, while institutions hold 11.69% stake in the company. Shares short for ACB as of 1760486400 were 6569314 with a Short Ratio of 3.72, compared to 1757894400 on 6568797.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 1 analysts currently analyzing and rating the stock of Aurora Cannabis Inc (ACB).The consensus estimate for the next quarter is -$0.05, with high estimates of -$0.05 and low estimates of -$0.05.
Analysts are recommending an EPS of between -$0.17 and -$0.43 for the fiscal current year, implying an average EPS of -$0.3. EPS for the following year is $0.1, with 2.0 analysts recommending between $0.3 and -$0.09.
Revenue Estimates
4 analysts predict $86.45M in revenue for. The current quarter. It ranges from a high estimate of $93.7M to a low estimate of $83M. As of. The current estimate, Aurora Cannabis Inc’s year-ago sales were $81.12MFor the next quarter, 4 analysts are estimating revenue of $91.08M. There is a high estimate of $102.8M for the next quarter, whereas the lowest estimate is $84.9M.
A total of 4 analysts have provided revenue estimates for ACB’s current fiscal year. The highest revenue estimate was $399.5M, while the lowest revenue estimate was $357.3M, resulting in an average revenue estimate of $371.93M. In the same quarter a year ago, actual revenue was $343.29MBased on 3 analysts’ estimates, the company’s revenue will be $383.17M in the next fiscal year. The high estimate is $385M and the low estimate is $381.5M.
